American Health Council Names Kenneth C. Anderson, M.D. to Physician Board

    NEW YORK, NY, April 18, 2017 /24-7PressRelease/ -- Dr. Kenneth C. Anderson, Director at Jerome Lipper Multiple Myeloma Center at the Dana-Farber Cancer Institute, has been selected to join the Physician Board at the American Health Council. He will be sharing his knowledge and expertise on Multiple Myeloma, Hematologic Malignancies, Targeted Therapies, Immune Therapies, Stem Cell Transplantation, and Blood Banking.

With over four decades of experience in the field of Hematology, Dr. Anderson offers valuable insight in his role as the Director at Jerome Lipper Multiple Myeloma Center at the Dana-Farber Cancer Institute. He also serves as the Kraft Family Professor of Medicine and Vice Chair of the Joint Program in Transfusion Medicine at Harvard Medical School. As a recognized name in the international research community, Dana-Farber Cancer Institute employs over four thousand professionals focused on conducting community-based programs in cancer prevention, detection and control supported by the National Cancer Institute, the Nation Institute of Allergy, and Infectious Diseases. By collaborating with other hospitals and research institutes, Dana-Farber Cancer Institute prides itself in providing the best possible care for children and adults with cancer while working towards prevention, treatment, and a cure.

As the Director at Jerome Lipper Multiple Myeloma Center at the Dana-Farber Cancer Institute, Dr. Anderson's day-to-day responsibilities include bench to bedside translation of multiple novel therapies which have improved patient outcome in myeloma, and training the next generation of myeloma leaders internationally.

In 1977, Dr. Anderson earned his Medical Degree from the Johns Hopkins University School of Medicine. To further his educational development, he completed a residency program at Johns Hopkins University School of Medicine. Dr. Anderson went on to complete an Oncology Fellowship at Dana-Farber Cancer Institute. He is a Doris Duke Clinical Research Scientist and an American Cancer Society Clinical Research Professor.

Dr. Anderson has served the American Society of Hematology (ASH) as Councilor on the Executive Committee, as Executive Editor of Hematology (the ASH Education Program), as Co-Chair of the inaugural ASH Meeting on Hematologic Malignancies, and is currently President of ASH. His goals focus on identifying new opportunities to attract and groom the next generation of hematologists through mentorship opportunities with experts in the field. He seeks to continue the society's strong record of advocating for sound investment in innovative science, including precision medicine and immunologic therapies, in addition to exploring new avenues for increasing quality and access to care around the world.

Dr. Anderson maintains affiliations with the American Society of Hematology, American Association for Cancer Research, American Society for Clinical Oncology, Institute of Medicine, and International Myeloma Society. His volunteer services include the Ron Burton Training Village, Jimmy Fund, Multiple Myeloma Research Foundation, International Myeloma Foundation, Leukemia and Lymphoma Society, and American Cancer Society.

Due to his strides in the field of Hematology, Dr. Anderson has been elected into the Johns Hopkins Society of Scholars, the Institute of Medicine of the National Academy of Sciences, and the Royal College of Physicians and of Pathologists, UK.

Dr. Anderson's desire to pursue the field of Hematology developed through his interaction with his mentor, Dr. Richard L. Humphrey, who sparked his interest in the translation of science to patient care. Looking back, he attributes his success to receiving inspiration from his patients and coworkers.

Some notable honors and awards Dr. Anderson has received throughout out his career include: 2003 International Myeloma Workshop Waldenstroms Award, 2005 International Myeloma Foundation Robert A. Kyle Lifetime Achievement Award, 2007 American Association for Cancer Research Joseph H. Burchenal Award, 2008 American Society of Hematology William Dameshek Prize, 2011 American Society of Clinical Oncology David A. Karnofsky Award, and the 2012 American Cancer Society Medal of Honor in Science.

Dr. Anderson is grateful for the loving support from his wife and three children. In his free time, he enjoys traveling, listening to music, and watching sports.

Considering the future, Dr. Anderson hopes for the discovery and validation of new targets and immune strategies, with translation to clinical trials and more effective therapies. He hopes for the development of an international genomically profiled clinically annotated data base in myeloma, and to mentor the next generation of translational research leaders.

# # #